Traditional endotoxin testing has long had pain points including analyst subjectivity, extensive training requirements, and the potential for data integrity violations. An invalid test can result in lengthy investigations, costly retests, and the risk of an FDA finding or audit, possibly crippling your manufacturing timelines.

While LAL is the most sensitive and reliable method available, technology has improved how it’s utilized, and we’ve evolved with your needs for a simpler, faster, and more robust assay.

What if there was a way to reduce analyst training, retest rates, and eliminate human error in data entry, collection, and interpretation?